Difficulty: Medium
Average Score: 84%
Practice
The drug of choice for hyperkinetic children is
Correct answer
A
Rationale
The correct answer is A) Methylphenidate for hyperkinetic children. Methylphenidate is a central nervous system stimulant commonly used to treat attention deficit hyperactivity disorder (ADHD) in children. It works by increasing the levels of certain neurotransmitters in the brain, helping to improve focus, attention, and impulse control in hyperactive children.
Option B) Nikethamide is not the drug of choice for hyperkinetic children. Nikethamide is a respiratory stimulant used to treat respiratory depression, not ADHD or hyperactivity.
Option C) Caffeine is a stimulant but is not the drug of choice for hyperkinetic children. Caffeine can exacerbate hyperactivity and is not recommended for children with ADHD.
Option D) Clonazepam is a benzodiazepine, which is a central nervous system depressant. It is not the drug of choice for hyperkinetic children as it can worsen symptoms of hyperactivity and is not indicated for ADHD.
In an educational context, understanding the appropriate pharmacological treatment for hyperkinetic children is crucial for healthcare professionals working with pediatric patients. By knowing the mechanism of action and appropriate use of medications like methylphenidate, nurses and other healthcare providers can effectively manage symptoms and improve outcomes for children with ADHD. It is important to be able to differentiate between various CNS stimulants and depressants to provide safe and effective care for pediatric patients with neurobehavioral disorders.
Option B) Nikethamide is not the drug of choice for hyperkinetic children. Nikethamide is a respiratory stimulant used to treat respiratory depression, not ADHD or hyperactivity.
Option C) Caffeine is a stimulant but is not the drug of choice for hyperkinetic children. Caffeine can exacerbate hyperactivity and is not recommended for children with ADHD.
Option D) Clonazepam is a benzodiazepine, which is a central nervous system depressant. It is not the drug of choice for hyperkinetic children as it can worsen symptoms of hyperactivity and is not indicated for ADHD.
In an educational context, understanding the appropriate pharmacological treatment for hyperkinetic children is crucial for healthcare professionals working with pediatric patients. By knowing the mechanism of action and appropriate use of medications like methylphenidate, nurses and other healthcare providers can effectively manage symptoms and improve outcomes for children with ADHD. It is important to be able to differentiate between various CNS stimulants and depressants to provide safe and effective care for pediatric patients with neurobehavioral disorders.